Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation.
Minas V, Rolaki A, Kalantaridou SN, Sidiropoulos J, Mitrou S, Petsas G, Jeschke U, Paraskevaidis EA, Fountzilas G, Chrousos GP, Pavlidis N, Makrigiannakis A.
Minas V, et al. Among authors: jeschke u.
Br J Cancer. 2007 Sep 3;97(5):637-45. doi: 10.1038/sj.bjc.6603918. Epub 2007 Jul 31.
Br J Cancer. 2007.
PMID: 17667919
Free PMC article.